Activated Stat3 expression in gestational trophoblastic disease: Correlation with clinicopathological parameters and apoptotic indices

Histopathology

Volumn 53, Issue 2, 2008, Pages 139-146

  Chan, H Y ^a   Siu, M K Y ^a   Zhang, H J ^a   Wong, E S Y ^a   Ngan, H Y S ^a   Chan, K Y K ^a   Cheung, A N Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Gestational trophoblastic disease; Stat3

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DNA NUCLEOTIDYLEXOTRANSFERASE; STAT3 PROTEIN;

APOPTOSIS; ARTICLE; CHORIOCARCINOMA; GENE CONTROL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TROPHOBLASTIC TUMOR; WESTERN BLOTTING;

APOPTOSIS; CELL LINE; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PHOSPHORYLATION; PREGNANCY; STAT3 TRANSCRIPTION FACTOR; TROPHOBLASTIC TUMOR, PLACENTAL SITE; UTERINE NEOPLASMS;

EID: 47749120647     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03089.x     Document Type: Article

References (43)

1. Paradinas FJ, Elston CW. Gestational trophoblastic diseases. In Fox H, Wells M eds. Haines and Taylor obstetrical and gynaecological patholog. Edinburgh: Churchill Livingstone, 2003 1359 1430.
2. Shih IM, Mazur MT, Kurman RJ. Gestational trophoblastic diseases and related lesions. In Kurman RJ ed. Blaustein's pathology of the female genital trac. New York: Springer-Verlag, 2002 1193 1224.
3. Ngan HY, Lopes AD, Lauder IJ, Martin BH, Wong LC, Ma HK. An evaluation of the prognostic factors in metastatic gestational trophoblastic disease. Int. J. Gynecol. Cancer. 1994 4 36 42.
4. Cheung AN. Pathology of gestational trophoblastic diseases. Best Pract. Res. Clin. Obstet. Gynaecol. 2003 17 849 868.
5. Darnell JE Jr., Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994 264 1415 1421.
6. Schindler C, Darnell JE Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 1995 64 621 651.
7. Darnell JE Jr. STATs and gene regulation. Science 1997 277 1630 1635.
8. Bromberg J, Darnell JE Jr. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000 19 2468 2473.
9. Niwa H, Burdon T, Chambers I, Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 1998 12 2048 2060.
10. Aggarwal BB, Sethi G, Ahn KS et al. Targeting signal-transducer-and- activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann. NY Acad. Sci. 2006 1091 151 169.
11. Azare J, Leslie K, Al-Ahmadie H et al. Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin beta 6. Mol. Cell. Biol. 2007 27 4444 4453.
12. Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000 19 2474 2488.
13. Calo V, Migliavacca M, Bazan V et al. STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell. Physiol. 2003 197 157 168.
14. Mui AL. The role of STATs in proliferation, differentiation, and apoptosis. Cell. Mol. Life Sci. 1999 55 1547 1558.
15. Page C, Huang M, Jin X et al. Elevated phosphorylation of AKT and Stat3 in prostate, breast, and cervical cancer cells. Int. J. Oncol. 2000 17 23 28.
16. Germain D, Frank DA. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clin. Cancer Res. 2007 13 5665 5669.
17. Poehlmann TG, Fitzgerald JS, Meissner A et al. Trophoblast invasion: tuning through LIF, signalling via Stat3. Placenta 2005 26 (Suppl. A S37 S41.
18. Fitzgerald JS, Tsareva SA, Poehlmann TG et al. Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells. Int. J. Biochem. Cell Biol. 2005 37 2284 2296.
19. Corvinus FM, Fitzgerald JS, Friedrich K, Markert UR. Evidence for a correlation between trophoblast invasiveness and STAT3 activity. Am. J. Reprod. Immunol. 2003 50 316 321.
20. Wen Z, Darnell JE Jr. Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res. 1997 25 2062 2067.
21. Wen Z, Zhong Z, Darnell JE Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995 82 241 250.
22. Cheung AN, Khoo US, Lai CY et al. Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis. Cancer 2004 100 1411 1417.
23. Lai CY, Chan KY, Khoo US et al. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization. Mod. Pathol. 2004 17 40 48.
24. Chiu PM, Ngan YS, Khoo US, Cheung AN. Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody. Histopathology 2001 38 243 249.
25. Wong SY, Ngan HY, Chan CC, Cheung AN. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression. Mod. Pathol. 1999 12 1025 1033.
26. Xue WC, Feng HC, Chan KY et al. Id helix-loop-helix proteins are differentially expressed in gestational trophoblastic disease. Histopathology 2005 47 303 309.
27. Xue WC, Khoo US, Ngan HY et al. Minichromosome maintenance protein 7 expression in gestational trophoblastic disease: correlation with Ki67, PCNA and clinicopathological parameters. Histopathology 2003 43 485 490.
28. Feng HC, Choy MY, Deng W et al. Establishment and characterization of a human first-trimester extravillous trophoblast cell line (TEV-1). J. Soc. Gynecol. Investig. 2005 12 e21 e32.
29. Xue WC, Feng HC, Tsao SW et al. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases. Int. J. Gynecol. Cancer. 2003 13 879 888.
30. Rosen DG, Mercado-Uribe I, Yang G et al. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer 2006 107 2730 2740.
31. Denson LA. Adding fuel to the fire: STAT3 priming of gastric tumorigenesis. Gastroenterology 2006 131 1342 1344.
32. Judd LM, Bredin K, Kalantzis A, Jenkins BJ, Ernst M, Giraud AS. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology 2006 131 1073 1085.
33. Sumita N, Bito T, Nakajima K, Nishigori C. Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines. Exp. Dermatol. 2006 15 291 299.
34. Jain N, Zhang T, Fong SL, Lim CP, Cao X. Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK). Oncogene 1998 17 3157 3167.
35. Chung J, Uchida E, Grammer TC, Blenis J. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell. Biol. 1997 17 6508 6516.
36. Lim CP, Cao X. Regulation of Stat3 activation by MEK kinase 1. J. Biol. Chem. 2001 276 21004 21011.
37. Sengupta TK, Talbot ES, Scherle PA, Ivashkiv LB. Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases. Proc. Natl. Acad. Sci. USA 1998 95 11107 11112.
38. Fong PY, Xue WC, Ngan HY et al. Mcl-1 expression in gestational trophoblastic disease correlates with clinical outcome: a differential expression study. Cancer 2005 103 268 276.
39. Xue WC, Chan KY, Feng HC et al. Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma. J. Mol. Diagn. 2004 6 326 334.
40. Battle TE, Frank DA. The role of STATs in apoptosis. Curr. Mol. Med. 2002 2 381 392.
41. Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000 19 2548 2556.
42. Levy DE, Darnell JE Jr. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 2002 3 651 662.
43. Sato N, Kawai T, Sugiyama K et al. Physical and functional interactions between STAT3 and ZIP kinase. Int. Immunol. 2005 17 1543 1552.